PANTOPRAZOLE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pantoprazole, and when can generic versions of Pantoprazole launch?
Pantoprazole is a drug marketed by Ajanta Pharma Ltd, Annora Pharma, Aurobindo Pharma Ltd, Cipla, Dexcel, Sun Pharm, Alembic, Aspiro, Be Pharms, Deva Holding As, Epic Pharma Llc, Eugia Pharma, Gland, Hangzhou Zhongmei, Knack, Meitheal, Pharmobedient, Sandoz, Fresenius Kabi Usa, Hikma, Actavis Totowa, Amneal Pharms, Apotex, Dr Reddys Labs Ltd, Granules, Graviti Pharms, Hetero Labs Ltd V, Ingenus Pharms Llc, Jubilant Generics, L Perrigo Co, Lannett Co Inc, Macleods Pharms Ltd, Mankind Pharma, Mylan Pharms Inc, Orbion Pharms, Rubicon Research, Sun Pharm Inds Ltd, Teva, Torrent Pharms, and Baxter Hlthcare Corp. and is included in forty-three NDAs.
The generic ingredient in PANTOPRAZOLE is pantoprazole sodium. There are forty-eight drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the pantoprazole sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pantoprazole
A generic version of PANTOPRAZOLE was approved as pantoprazole sodium by APOTEX on January 19th, 2011.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PANTOPRAZOLE?
- What are the global sales for PANTOPRAZOLE?
- What is Average Wholesale Price for PANTOPRAZOLE?
Summary for PANTOPRAZOLE
| US Patents: | 0 |
| Applicants: | 40 |
| NDAs: | 43 |
| Drug Prices: | Drug price information for PANTOPRAZOLE |
| Drug Sales Revenues: | Drug sales revenues for PANTOPRAZOLE |
| DailyMed Link: | PANTOPRAZOLE at DailyMed |
US Patents and Regulatory Information for PANTOPRAZOLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L Perrigo Co | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 203024-001 | May 7, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Granules | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 217282-001 | Dec 11, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mylan Pharms Inc | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 090970-002 | Jan 19, 2011 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Torrent Pharms | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 090074-001 | Jan 19, 2011 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
